![IJMS | Free Full-Text | Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye | HTML IJMS | Free Full-Text | Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye | HTML](https://www.mdpi.com/ijms/ijms-22-00116/article_deploy/html/images/ijms-22-00116-g001.png)
IJMS | Free Full-Text | Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye | HTML
Full article: A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry
![AbbVie's blockbuster eye drug Restasis under threat as FDA approves Viatris' copycat | Fierce Pharma AbbVie's blockbuster eye drug Restasis under threat as FDA approves Viatris' copycat | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1643835329/abbvie.jpg/abbvie.jpg?VersionId=8VURNjG8iR7V9Kz2fQZdBdzvNpnPbKaU)